ED Treatment Market Insights, Global Outlook and Forecast 2022-2028
ED Treatment Market Insights, Global Outlook and Forecast 2022-2028
ED Treatment Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The latest research study released by Market IntelliX evaluates market size and forecasts of ED Treatment in global, including the following market information:
Global ED Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global ED Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five ED Treatment companies in 2021 (%)
The global ED Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sildenafil Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of ED Treatment include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma and Seoul Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the ED Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global ED Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global ED Treatment Market Segment Percentages, by Type, 2021 (%)
Sildenafil
Tadalafil
Others
Global ED Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global ED Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drugstores
Other
Global ED Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global ED Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies ED Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies ED Treatment revenues share in global market, 2021 (%)
Key companies ED Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies ED Treatment sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 ED Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global ED Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global ED Treatment Overall Market Size
2.1 Global ED Treatment Market Size: 2021 VS 2028
2.2 Global ED Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global ED Treatment Sales: 2017-2028
3 Company Landscape
3.1 Top ED Treatment Players in Global Market
3.2 Top Global ED Treatment Companies Ranked by Revenue
3.3 Global ED Treatment Revenue by Companies
3.4 Global ED Treatment Sales by Companies
3.5 Global ED Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 ED Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers ED Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 ED Treatment Players in Global Market
3.8.1 List of Global Tier 1 ED Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 ED Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global ED Treatment Market Size Markets, 2021 & 2028
4.1.2 Sildenafil
4.1.3 Tadalafil
4.1.4 Others
4.2 By Type - Global ED Treatment Revenue & Forecasts
4.2.1 By Type - Global ED Treatment Revenue, 2017-2022
4.2.2 By Type - Global ED Treatment Revenue, 2023-2028
4.2.3 By Type - Global ED Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global ED Treatment Sales & Forecasts
4.3.1 By Type - Global ED Treatment Sales, 2017-2022
4.3.2 By Type - Global ED Treatment Sales, 2023-2028
4.3.3 By Type - Global ED Treatment Sales Market Share, 2017-2028
4.4 By Type - Global ED Treatment Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global ED Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Other
5.2 By Application - Global ED Treatment Revenue & Forecasts
5.2.1 By Application - Global ED Treatment Revenue, 2017-2022
5.2.2 By Application - Global ED Treatment Revenue, 2023-2028
5.2.3 By Application - Global ED Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global ED Treatment Sales & Forecasts
5.3.1 By Application - Global ED Treatment Sales, 2017-2022
5.3.2 By Application - Global ED Treatment Sales, 2023-2028
5.3.3 By Application - Global ED Treatment Sales Market Share, 2017-2028
5.4 By Application - Global ED Treatment Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global ED Treatment Market Size, 2021 & 2028
6.2 By Region - Global ED Treatment Revenue & Forecasts
6.2.1 By Region - Global ED Treatment Revenue, 2017-2022
6.2.2 By Region - Global ED Treatment Revenue, 2023-2028
6.2.3 By Region - Global ED Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global ED Treatment Sales & Forecasts
6.3.1 By Region - Global ED Treatment Sales, 2017-2022
6.3.2 By Region - Global ED Treatment Sales, 2023-2028
6.3.3 By Region - Global ED Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America ED Treatment Revenue, 2017-2028
6.4.2 By Country - North America ED Treatment Sales, 2017-2028
6.4.3 US ED Treatment Market Size, 2017-2028
6.4.4 Canada ED Treatment Market Size, 2017-2028
6.4.5 Mexico ED Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe ED Treatment Revenue, 2017-2028
6.5.2 By Country - Europe ED Treatment Sales, 2017-2028
6.5.3 Germany ED Treatment Market Size, 2017-2028
6.5.4 France ED Treatment Market Size, 2017-2028
6.5.5 U.K. ED Treatment Market Size, 2017-2028
6.5.6 Italy ED Treatment Market Size, 2017-2028
6.5.7 Russia ED Treatment Market Size, 2017-2028
6.5.8 Nordic Countries ED Treatment Market Size, 2017-2028
6.5.9 Benelux ED Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia ED Treatment Revenue, 2017-2028
6.6.2 By Region - Asia ED Treatment Sales, 2017-2028
6.6.3 China ED Treatment Market Size, 2017-2028
6.6.4 Japan ED Treatment Market Size, 2017-2028
6.6.5 South Korea ED Treatment Market Size, 2017-2028
6.6.6 Southeast Asia ED Treatment Market Size, 2017-2028
6.6.7 India ED Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America ED Treatment Revenue, 2017-2028
6.7.2 By Country - South America ED Treatment Sales, 2017-2028
6.7.3 Brazil ED Treatment Market Size, 2017-2028
6.7.4 Argentina ED Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa ED Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa ED Treatment Sales, 2017-2028
6.8.3 Turkey ED Treatment Market Size, 2017-2028
6.8.4 Israel ED Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia ED Treatment Market Size, 2017-2028
6.8.6 UAE ED Treatment Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly ED Treatment Major Product Offerings
7.1.4 Eli Lilly ED Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer ED Treatment Major Product Offerings
7.2.4 Pfizer ED Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer ED Treatment Major Product Offerings
7.3.4 Bayer ED Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Bayer Key News
7.4 BaiYunShan General Factory
7.4.1 BaiYunShan General Factory Corporate Summary
7.4.2 BaiYunShan General Factory Business Overview
7.4.3 BaiYunShan General Factory ED Treatment Major Product Offerings
7.4.4 BaiYunShan General Factory ED Treatment Sales and Revenue in Global (2017-2022)
7.4.5 BaiYunShan General Factory Key News
7.5 S.K. Chemicals
7.5.1 S.K. Chemicals Corporate Summary
7.5.2 S.K. Chemicals Business Overview
7.5.3 S.K. Chemicals ED Treatment Major Product Offerings
7.5.4 S.K. Chemicals ED Treatment Sales and Revenue in Global (2017-2022)
7.5.5 S.K. Chemicals Key News
7.6 Teva Pharma
7.6.1 Teva Pharma Corporate Summary
7.6.2 Teva Pharma Business Overview
7.6.3 Teva Pharma ED Treatment Major Product Offerings
7.6.4 Teva Pharma ED Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Teva Pharma Key News
7.7 Dong-A ST
7.7.1 Dong-A ST Corporate Summary
7.7.2 Dong-A ST Business Overview
7.7.3 Dong-A ST ED Treatment Major Product Offerings
7.7.4 Dong-A ST ED Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Dong-A ST Key News
7.8 Metuchen Pharma
7.8.1 Metuchen Pharma Corporate Summary
7.8.2 Metuchen Pharma Business Overview
7.8.3 Metuchen Pharma ED Treatment Major Product Offerings
7.8.4 Metuchen Pharma ED Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Metuchen Pharma Key News
7.9 Seoul Pharma
7.9.1 Seoul Pharma Corporate Summary
7.9.2 Seoul Pharma Business Overview
7.9.3 Seoul Pharma ED Treatment Major Product Offerings
7.9.4 Seoul Pharma ED Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Seoul Pharma Key News
7.10 CSBIO.
7.10.1 CSBIO. Corporate Summary
7.10.2 CSBIO. Business Overview
7.10.3 CSBIO. ED Treatment Major Product Offerings
7.10.4 CSBIO. ED Treatment Sales and Revenue in Global (2017-2022)
7.10.5 CSBIO. Key News
8 Global ED Treatment Production Capacity, Analysis
8.1 Global ED Treatment Production Capacity, 2017-2028
8.2 ED Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global ED Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ED Treatment Supply Chain Analysis
10.1 ED Treatment Industry Value Chain
10.2 ED Treatment Upstream Market
10.3 ED Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 ED Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
ED Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|